No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Ingemar Lagerlöf,Harald Holte,Ingrid Glimelius,Magnus Björkholm,Gunilla Enblad,Martin Erlanson,Øystein Fluge,Helena Fohlin,Alexander Fosså,Christina Goldkuhl,Anita Gustavsson,Ann-Sofie Johansson,Johan Linderoth,Ole Nome,Marzia Palma,Lisa Åkesson,Bjørn Østenstad,Cecilia Raud,Bengt Glimelius,Daniel Molin

No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

2019

When treating limited stage classical Hodgkin lymphoma (cHL), balancing treatment efficacy and toxicity is important. Toxicities after extended-field radiotherapy are well documented. Investigators ...

Keywords:

ABVD
Radiation therapy
Internal medicine
Diabetes mellitus
Oncology
Limited Stage
Relative survival
Medicine
Lymphoma
Immunology
Hematology
hodgkin lymphoma
Toxicity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations